Liberty Foreman, CEO of DynamX Medical – a software company that has developed novel technology to streamline disease diagnosis – has been featured in the 2020 Forbes 30 Under 30 list. Liberty has been named in the prestigious European Science and Healthcare category. The list chronicles pioneering entrepreneurs in the field under the age of 30, and pays tribute to up-and-coming innovators who are making a significant impact on the industry.

I am absolutely delighted to be featured in the distinguished Forbes 30 Under 30 Science and Healthcare list. It is a fantastic acknowledgement of the work not just I, but the whole DynamX team has put into developing pioneering new technology to facilitate affordable and accessible disease diagnosis.

Liberty Foreman – CEO

DynamX Medical’s diagnostic technology uses a novel algorithm to combine widely available infrared spectroscopy, machine learning and AI. It works by recognising spectral patterns unique to healthy patients and separating them from the cohort. As a result, the technology promises to streamline workflows by significantly reducing the time taken to diagnose diseases, improving efficiency in healthcare.

Liberty’s inclusion in the Forbes 30 Under 30 list is in recognition of the transformative power of DynamX Medical’s products, which has led the company to raise almost $4 million USD in investments, grants and contracts to date. The technology is now in final trials in 4 UK hospitals, and is expected to become commercially available within 18 months of the next funding round.